文献速递主动脉疾病

体外循环辅助与开放性胸主动脉及胸腹主动脉瘤修复术后结局改善相关

Use of extracorporeal bypass is associated with improved outcomes in open thoracic and thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2018-03-31

基于美国Medicare 2004-2007年数据,纳入4230例非破裂性降主动脉或胸腹主动脉瘤开放修复患者,其中2433例(57%)使用体外循环。多因素回归显示体外循环独立降低手术死亡(OR 0.80)、任何并发症(OR 0.67)、肺部并发症(OR 0.68)和急性肾衰竭(OR 0.52),并改善远期生存(HR 0.69)。

要点

  • 体外循环组30天死亡率9.7% vs 非体外循环组12.2%(P = .02)。
  • 体外循环组任何主要并发症49% vs 非体外循环组58%(P < .001)。
  • 体外循环独立降低手术死亡(OR 0.80;95%CI 0.65-0.97;P = .02)。

核心结论

  • 在开放性降主动脉和胸腹主动脉瘤修复中,使用体外循环与远期生存改善及手术死亡率、并发症和手术费用的显著降低相关。
  • 作者认为这些数据表明体外循环应作为开放性降主动脉或胸腹主动脉瘤修复中更广泛应用的辅助手段。

研究设计与样本

  • 基于美国Medicare 2004-2007年数据的回顾性分析,纳入4230例非破裂性降主动脉或胸腹主动脉瘤开放修复患者,其中2433例(57%)使用体外循环。
  • 排除升主动脉或弓部修复、同期心脏手术及采用深低温停循环的手术。
  • 采用单因素分析和多因素回归分析体外循环对早期和晚期结局的影响,生存分析采用Kaplan-Meier法和Cox比例风险回归模型。

主要发现

  • 体外循环组与非体外循环组基线差异:年龄73 ± 1岁 vs 72 ± 1岁(P = .002),女性53% vs 47%(P < .001),高血压56% vs 53%(P = .02),慢性阻塞性肺疾病28% vs 34%(P < .0001),外周血管疾病5.7% vs 11.3%(P < .001),慢性肾脏病7.7% vs 5.5%(P = .003)。
  • 体外循环组30天死亡率9.7% vs 非体外循环组12.2%(P = .02),任何主要并发症49% vs 58%(P < .001)。
  • 体外循环组住院时间13.5 ± 13天 vs 非体外循环组17.2 ± 18天(P < .01),总住院费用$151,000 ± 140,000 vs $180,000 ± 190,000(P < .01)。
  • 体外循环组出院回家比例67% vs 非体外循环组56%(P < .01)。
  • 多因素回归显示体外循环独立降低手术死亡(OR 0.80;95%CI 0.65-0.97;P = .02)、任何并发症(OR 0.67;95%CI 0.59-0.76;P < .01)、肺部并发症(OR 0.68;95%CI 0.59-0.79;P < .01)和急性肾衰竭(OR 0.52;95%CI 0.44-0.61;P < .01)。

临床怎么用

  • 作者认为体外循环应作为开放性降主动脉或胸腹主动脉瘤修复中更广泛应用的辅助手段。
  • 原文未据此给出具体的患者选择标准或操作推荐。

局限性

  • 原文指出Medicare数据库无法评估降主动脉或胸腹主动脉瘤范围及脊髓缺血并发症等重要临床变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is no consensus on the use or benefit of extracorporeal circulation (EC) during aneurysm repair of the descending thoracic aorta (DTA) or thoracoabdominal aorta (TAA). We evaluated the role of EC during DTA or TAA aneurysm repair using U.S. Medicare data. METHODS: Medicare (2004-2007) patients undergoing open repair of nonruptured DTA or TAA aneurysm were identified by International Classification of Diseases, Ninth Revision code. Specific exclusions included ascending aortic or arch repairs, concomitant cardiac procedures, and procedures employing deep hypothermic circulatory arrest. The impact of EC (code 3961) on early and late outcomes was analyzed using univariate analysis and multivariable regression. Survival was assessed using Kaplan-Meier analysis and Cox proportional hazards regression models. RESULTS: There were 4230 patients who had repair of intact DTA or TAA aneurysms, 2433 (57%) of which employed EC. Differences in baseline clinical features of EC and non-EC patients showed that patients undergoing aortic reconstruction with EC were older (73 ± 1 years vs 72 ± 1 years; P = .002), were more likely to be female (53% vs 47%; P < .001), and had more hypertension (56% vs 53%; P = .02); they had less chronic obstructive pulmonary disease (28% vs 34%; P < .0001), peripheral vascular disease (5.7% vs 11.3%; P < .001), and chronic kidney disease (7.7% vs 5.5%; P = .003). The 30-day mortality (9.7% for EC vs 12.2%; P = .02) and any major complication (49% for EC vs 58%; P < .001) were significantly reduced with EC use. EC use was associated with a shorter length of stay (13.5 ± 13 days vs 17.2 ± 18 days; P < .01) and lower total hospital charges ($151,000 ± 140,000 vs $180,000 ± 190,000; P < .01) compared with non-EC patients. EC patients were more likely to be discharged home instead of to an extended care facility (67% vs 56%; P < .01). Multivariable regression modeling to adjust for baseline clinical differences showed EC to independently reduce the risk of operative mortality (odds ratio [OR], 0.80; 95% confidence interval [CI], 0.65-0.97; P = .02), any complication (OR, 0.67; 95% CI, 0.59-0.76; P < .01), pulmonary complications (OR, 0.68; 95% CI, 0.59-0.79; P < .01), and acute renal failure (OR, 0.52; 95% CI, 0.44-0.61; P < .01). Long-term survival was higher (log-rank, P < .01) in EC patients at 1 year (81% ± 0.8% vs 73% ± 1%) and 5 years (67% ± 1% vs 52% ± 1%). Risk-adjusted Cox proportional hazards regression also showed that EC was independently associated with improved long-term survival (hazard ratio, 0.69; 95% CI, 0.63-0.74; P < .01). CONCLUSIONS: Although important clinical variables such as DTA or TAA aneurysm extent and spinal cord ischemic complications cannot be assessed with the Medicare database, EC use during open DTA and TAA aneurysm repair is associated with improved late survival and a significant reduction in operative mortality, morbidity, and procedural costs. These data indicate that EC should be a more widely applied adjunct in open DTA or TAA aneurysm repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mohebali J, Carvalho S, Lancaster RT, et al. Use of extracorporeal bypass is associated with improved outcomes in open thoracic and thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2018. PMID: 29615357. doi:10.1016/j.jvs.2017.12.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。